Developing a Method to Objectively Measure Opioid Analgesia

Launched by JULIA FINKEL · Jul 27, 2018

Keywords

ClinConnect Summary

This clinical trial is studying a new device designed to measure how well opioid pain medications are working for patients, especially in young people aged 7 to 21 who are receiving these medications after surgery or in the pediatric intensive care unit. The goal is to find a more objective way to assess pain relief and ensure that the right dose of medication is given, which could help prevent problems related to opioid misuse.

To be eligible for the study, participants need to be within the specified age range and currently receiving opioids either through a controlled pump or as part of their treatment in the hospital. They must also be able to give or have a parent give consent to participate. However, those with certain eye conditions that prevent specific eye tests or those who are not stable in their condition will not be able to join. Participants can expect to help researchers improve pain management practices, which might lead to better treatment options for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The subject is 7 to 21 years of age
• • 2. The subject is receiving an opioid via bolus or a patient controlled analgesia (PCA) apparatus as part of treatment or fentanyl infusion in the pediatric intensive care unit (PICU) (generally postoperative patients).
• • 3. The subject is willing and able to provide written informed assent/parental consent to study participation
• Exclusion Criteria:
• • 1. Eye pathology precluding pupillometry
• • 2. For patients in the PICU, patients who are hemodynamically unstable